FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2034162342> ?p ?o ?g. }

• W2034162342 endingPage "18" @default.
• W2034162342 startingPage "18" @default.
• W2034162342 abstract "Purpose Treatment options for patients with advanced gastric cancer remain limited. Few studies have investigated the efficacy and tolerability of the combination regimen of oxaliplatin and 5-fluorouracil with leucovorin for patients with advanced gastric cancer. The goal of this study was to examine the efficacy and toxicity of a modified FOLFOX-6 (mFOLFOX-6) regimen as a first-line chemotherapy regimen for patients with advanced gastric cancer. Materials and Methods From March, 2006, to December, 2007, 82 patients with advanced gastric cancer received 100 mg/m2 oxaliplatin and 100 mg/m2 leucovorin on the first day of treatment, followed by 2,400 mg/m2 of 5-fluorouracil on the first and second days of treatment every 2 weeks as a first-line treatment. Results The median age of the enrolled patients was 62 years (range; 30~75). Out of 82 patients, 34 cases (41.5%) were recurrent cases after curative resection, and the other 48 cases were unresectable or non-curative resectable cases. Their response was evaluated every 6 weeks. The overall response rate was 40.2%, with 2 (2.4%) complete response and 31 (37.8%) partial responses. The median time to progression (TTP) and overall survival (OS) time were 6.0 months (95% confidence interval [CI]: 4.69~7.31) and 13.0 months (7.99~18.0), respectively. The grade 3~4 hematologic toxicities observed included neutropenia (34.1%), thrombocytopenia (7.3%), and anemia (1.2%). The gastrointestinal toxicities observed included grade 3~4 nausea (9.8%) and vomiting (7.3%). Six patients (7.3%) experienced grade 3 neuropathy. No treatment-related deaths were recorded. Conclusion The modified FOLFOX-6 regimen is effective and well tolerated as a first-line chemotherapy regimen for patients with advanced gastric cancer. Key words: Stomach neoplasms, Adjuvant chemotherapy, Oxaliplatin, FOLFOX regimen" @default.
• W2034162342 created "2016-06-24" @default.
• W2034162342 creator A5017735770 @default.
• W2034162342 creator A5030930195 @default.
• W2034162342 creator A5044820152 @default.
• W2034162342 creator A5064153008 @default.
• W2034162342 creator A5080937552 @default.
• W2034162342 creator A5083705721 @default.
• W2034162342 date "2010-01-01" @default.
• W2034162342 modified "2023-09-26" @default.
• W2034162342 title "Outcomes of Modified FOLFOX-6 as First Line Treatment in Patients with Advanced Gastric Cancer in a Single Institution; Retrospective Analysis" @default.
• W2034162342 cites W1972239955 @default.
• W2034162342 cites W1986521453 @default.
• W2034162342 cites W2035185002 @default.
• W2034162342 cites W2039948221 @default.
• W2034162342 cites W2046158351 @default.
• W2034162342 cites W2060704373 @default.
• W2034162342 cites W2065982243 @default.
• W2034162342 cites W2074522417 @default.
• W2034162342 cites W2108661938 @default.
• W2034162342 cites W2121368761 @default.
• W2034162342 cites W2121543823 @default.
• W2034162342 cites W2122866527 @default.
• W2034162342 cites W2123495698 @default.
• W2034162342 cites W2128328462 @default.
• W2034162342 cites W2128403792 @default.
• W2034162342 cites W2128775037 @default.
• W2034162342 cites W2130522735 @default.
• W2034162342 cites W2208638853 @default.
• W2034162342 cites W2222330038 @default.
• W2034162342 cites W2282703690 @default.
• W2034162342 cites W2589845970 @default.
• W2034162342 doi "https://doi.org/10.4143/crt.2010.42.1.18" @default.
• W2034162342 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2848749" @default.
• W2034162342 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20369047" @default.
• W2034162342 hasPublicationYear "2010" @default.
• W2034162342 type Work @default.
• W2034162342 sameAs 2034162342 @default.
• W2034162342 citedByCount "15" @default.
• W2034162342 countsByYear W20341623422012 @default.
• W2034162342 countsByYear W20341623422014 @default.
• W2034162342 countsByYear W20341623422015 @default.
• W2034162342 countsByYear W20341623422016 @default.
• W2034162342 countsByYear W20341623422017 @default.
• W2034162342 countsByYear W20341623422018 @default.
• W2034162342 crossrefType "journal-article" @default.
• W2034162342 hasAuthorship W2034162342A5017735770 @default.
• W2034162342 hasAuthorship W2034162342A5030930195 @default.
• W2034162342 hasAuthorship W2034162342A5044820152 @default.
• W2034162342 hasAuthorship W2034162342A5064153008 @default.
• W2034162342 hasAuthorship W2034162342A5080937552 @default.
• W2034162342 hasAuthorship W2034162342A5083705721 @default.
• W2034162342 hasBestOaLocation W20341623421 @default.
• W2034162342 hasConcept C121608353 @default.
• W2034162342 hasConcept C126322002 @default.
• W2034162342 hasConcept C141071460 @default.
• W2034162342 hasConcept C197934379 @default.
• W2034162342 hasConcept C2776694085 @default.
• W2034162342 hasConcept C2777063308 @default.
• W2034162342 hasConcept C2778248108 @default.
• W2034162342 hasConcept C2778260052 @default.
• W2034162342 hasConcept C2778336483 @default.
• W2034162342 hasConcept C2778375690 @default.
• W2034162342 hasConcept C2780456651 @default.
• W2034162342 hasConcept C2780580376 @default.
• W2034162342 hasConcept C2780852908 @default.
• W2034162342 hasConcept C2780962732 @default.
• W2034162342 hasConcept C2781413609 @default.
• W2034162342 hasConcept C526805850 @default.
• W2034162342 hasConcept C71924100 @default.
• W2034162342 hasConcept C90924648 @default.
• W2034162342 hasConceptScore W2034162342C121608353 @default.
• W2034162342 hasConceptScore W2034162342C126322002 @default.
• W2034162342 hasConceptScore W2034162342C141071460 @default.
• W2034162342 hasConceptScore W2034162342C197934379 @default.
• W2034162342 hasConceptScore W2034162342C2776694085 @default.
• W2034162342 hasConceptScore W2034162342C2777063308 @default.
• W2034162342 hasConceptScore W2034162342C2778248108 @default.
• W2034162342 hasConceptScore W2034162342C2778260052 @default.
• W2034162342 hasConceptScore W2034162342C2778336483 @default.
• W2034162342 hasConceptScore W2034162342C2778375690 @default.
• W2034162342 hasConceptScore W2034162342C2780456651 @default.
• W2034162342 hasConceptScore W2034162342C2780580376 @default.
• W2034162342 hasConceptScore W2034162342C2780852908 @default.
• W2034162342 hasConceptScore W2034162342C2780962732 @default.
• W2034162342 hasConceptScore W2034162342C2781413609 @default.
• W2034162342 hasConceptScore W2034162342C526805850 @default.
• W2034162342 hasConceptScore W2034162342C71924100 @default.
• W2034162342 hasConceptScore W2034162342C90924648 @default.
• W2034162342 hasIssue "1" @default.
• W2034162342 hasLocation W20341623421 @default.
• W2034162342 hasLocation W20341623422 @default.
• W2034162342 hasLocation W20341623423 @default.
• W2034162342 hasLocation W20341623424 @default.
• W2034162342 hasOpenAccess W2034162342 @default.
• W2034162342 hasPrimaryLocation W20341623421 @default.
• W2034162342 hasRelatedWork W1993733741 @default.
• W2034162342 hasRelatedWork W2074189201 @default.

• next